These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23037012)

  • 21. Intracellular Calcium Dysregulation: Implications for Alzheimer's Disease.
    Magi S; Castaldo P; Macrì ML; Maiolino M; Matteucci A; Bastioli G; Gratteri S; Amoroso S; Lariccia V
    Biomed Res Int; 2016; 2016():6701324. PubMed ID: 27340665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Linking amyloid-β and tau: amyloid-β induced synaptic dysfunction via local wreckage of the neuronal cytoskeleton.
    Zempel H; Mandelkow EM
    Neurodegener Dis; 2012; 10(1-4):64-72. PubMed ID: 22156588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trafficking of Alzheimer's disease-related membrane proteins and its participation in disease pathogenesis.
    Suzuki T; Araki Y; Yamamoto T; Nakaya T
    J Biochem; 2006 Jun; 139(6):949-55. PubMed ID: 16788045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium dysregulation in Alzheimer's disease.
    Bojarski L; Herms J; Kuznicki J
    Neurochem Int; 2008; 52(4-5):621-33. PubMed ID: 18035450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amyloid precursor protein and mitochondrial dysfunction in Alzheimer's disease.
    Anandatheerthavarada HK; Devi L
    Neuroscientist; 2007 Dec; 13(6):626-38. PubMed ID: 17911214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased protein and lipid oxidative damage in mitochondria isolated from lymphocytes from patients with Alzheimer's disease: insights into the role of oxidative stress in Alzheimer's disease and initial investigations into a potential biomarker for this dementing disorder.
    Sultana R; Mecocci P; Mangialasche F; Cecchetti R; Baglioni M; Butterfield DA
    J Alzheimers Dis; 2011; 24(1):77-84. PubMed ID: 21383494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Crosstalk Between Pathological Tau Phosphorylation and Mitochondrial Dysfunction as a Key to Understanding and Treating Alzheimer's Disease.
    Guha S; Johnson GVW; Nehrke K
    Mol Neurobiol; 2020 Dec; 57(12):5103-5120. PubMed ID: 32851560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic/signal transduction hypothesis of Alzheimer's disease and other tauopathies.
    Iqbal K; Grundke-Iqbal I
    Acta Neuropathol; 2005 Jan; 109(1):25-31. PubMed ID: 15645264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitochondrial dysfunction: the first domino in brain aging and Alzheimer's disease?
    Leuner K; Hauptmann S; Abdel-Kader R; Scherping I; Keil U; Strosznajder JB; Eckert A; Müller WE
    Antioxid Redox Signal; 2007 Oct; 9(10):1659-75. PubMed ID: 17867931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amyloid-beta, tau, and dementia.
    Takashima A
    J Alzheimers Dis; 2009; 17(4):729-36. PubMed ID: 19542626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. March separate, strike together--role of phosphorylated TAU in mitochondrial dysfunction in Alzheimer's disease.
    Eckert A; Nisbet R; Grimm A; Götz J
    Biochim Biophys Acta; 2014 Aug; 1842(8):1258-66. PubMed ID: 24051203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitochondria-associated ER membranes in Alzheimer disease.
    Schon EA; Area-Gomez E
    Mol Cell Neurosci; 2013 Jul; 55():26-36. PubMed ID: 22922446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances.
    Wang W; Zhao F; Ma X; Perry G; Zhu X
    Mol Neurodegener; 2020 May; 15(1):30. PubMed ID: 32471464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Tau Protein on Mitochondrial Functions.
    Epremyan KK; Goleva TN; Zvyagilskaya RA
    Biochemistry (Mosc); 2022 Aug; 87(8):689-701. PubMed ID: 36171651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondrial traffic jams in Alzheimer's disease - pinpointing the roadblocks.
    Correia SC; Perry G; Moreira PI
    Biochim Biophys Acta; 2016 Oct; 1862(10):1909-17. PubMed ID: 27460705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitochondria in aging and Alzheimer's disease.
    Crouch PJ; Cimdins K; Duce JA; Bush AI; Trounce IA
    Rejuvenation Res; 2007 Sep; 10(3):349-57. PubMed ID: 17708691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dysfunction of Mitochondria in Alzheimer's Disease: ANT and VDAC Interact with Toxic Proteins and Aid to Determine the Fate of Brain Cells.
    Atlante A; Valenti D; Latina V; Amadoro G
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Mitocentric View of Alzheimer's Disease.
    Hu H; Tan CC; Tan L; Yu JT
    Mol Neurobiol; 2017 Oct; 54(8):6046-6060. PubMed ID: 27696116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metals and Neuronal Metal Binding Proteins Implicated in Alzheimer's Disease.
    Cristóvão JS; Santos R; Gomes CM
    Oxid Med Cell Longev; 2016; 2016():9812178. PubMed ID: 26881049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.